Table 2.
Monomer | Crosslinker |
cM (mol/L) |
cCL (mol%) |
qm,∞ | qv,∞ |
---|---|---|---|---|---|
MASO3 | BAP | 2 | 2 | 7.7 ± 0.3 | 10.7 ± 0.8 |
2.5 | 5.0 ± 0.9 | 4.1 ± 0.2 | |||
3 | 5.5 ± 0.2 | 6.8 ± 0.4 | |||
2.5 | 2 | 4.3 ± 0.1 | * | ||
2.5 | 5.1 ± 0.4 | 6.1 ± 0.9 | |||
3 | * | * | |||
3 | 2 | 4.9 ± 0.2 | * | ||
2.5 | 4.6 ± 0.3 | 5.7 ± 0.4 | |||
3 | 4.7 ± 0.9 | 5.2 ± 0.9 | |||
MBAA | 2 | 2 | 7.7 ± 0.3 | 10.7 ± 0.8 | |
2.5 | 4.4 ± 1.3 | * | |||
3 | 4.0 ± 0.2 | * | |||
MATMA | BAP | 3 | 2 | 4.9 ± 0.1 | 5.7 ± 0.2 |
MBAA | 3 | 2 | 5.4 ± 0.4 | 6.2 ± 0.2 | |
HEMA | BAP | 3 | 2 | 1.0 ± 0.1 | 0.6 ± 0.1 |
3 | 0.9 ± 0.1 | 0.9 ± 0.1 | |||
4 | 3 | 0.1 ± 0.0 | 0.1 ± 0.0 | ||
4 | 0.1 ± 0.0 | * | |||
MBAA | 3 | 2 | 1.0 ± 0.1 | 1.0 ± 0.3 | |
MADMASO3 | BAP | 2 | 2 | 2.8 ± 0.1 | 3.2 ± 0.2 |
AAMPSO3 | BAP | 2 | 2 | 2.1 ± 0.1 | 2.4 ± 0.4 |
2.5 | 1.8 ± 0.6 | 1.8 ± 0.5 | |||
3 | 1.7 ± 0.1 | 1.5 ± 0.2 | |||
2.5 | 2 | 2.5 ± 0.1 | 3.0 ± 0.2 | ||
2.5 | 1.8 ± 0.2 | 2.2 ± 0.2 | |||
3 | 1.7 ± 0.1 | * | |||
3 | 2 | * | * | ||
2.5 | 2.2 ± 0.1 | * | |||
3 | * | * | |||
VBTMA | BAP | 2 | 2 | 7.2 ± 0.3 | 7.3 ± 1.5 |
2.5 | 2.9 ± 0.4 | 2.3 ± 0.3 | |||
3 | 4.2 ± 0.3 | 2.5 ± 0.2 | |||
2.5 | 2 | 2.7 ± 0.2 | 2.5 ± 0.4 | ||
2.5 | 4.8 ± 0.9 | 2.7 ± 0.1 | |||
3 | 7.3 ± 0.7 | 5.9 ± 0.2 | |||
3 | 2 | 5.5 ± 0.4 | 6.7 ± 0.4 | ||
2.5 | 4.2 ± 0.3 | 4.3 ± 0.1 | |||
3 | 5.6 ± 0.7 | 4.2 ± 0.1 |
* not determined due to unsymmetrical swelling (qv,∞) or breakage of the hydrogel while swelling.